Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunomodulatory drugs for psoriasis.

× No keyword cloud information.

13 in total

Review 1. Novel immunotherapies for psoriasis.

Authors: Khusru Asadullah; Hans-Dieter Volk; Wolfram Sterry
Journal: Trends Immunol Date: 2002-01 Impact factor: 16.687

2. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

Authors: C N Ellis; G G Krueger
Journal: N Engl J Med Date: 2001-07-26 Impact factor: 91.245

3. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration.

Authors: S Lori Brown; Mark H Greene; Sharon K Gershon; Evelyne T Edwards; M Miles Braun
Journal: Arthritis Rheum Date: 2002-12

4. [The role of biologics into the management of psoriasis: a consensus paper by the Psoriasis Study Group, Arbeitsgemeinschaft Dermatologische Forschung].

Authors: Boehncke Wolf-Henning; Markus Friedrich; Ulrich Mrowietz; Kristian Reich; Thomas Rosenbach; Michael Sticherling; Diamant Thaçi
Journal: J Dtsch Dermatol Ges Date: 2003-08 Impact factor: 5.584

Review 5. Methotrexate in psoriasis: consensus conference.

Authors: H H Roenigk; R Auerbach; H Maibach; G Weinstein; M Lebwohl
Journal: J Am Acad Dermatol Date: 1998-03 Impact factor: 11.527

6. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.

Authors: U Chaudhari; P Romano; L D Mulcahy; L T Dooley; D G Baker; A B Gottlieb
Journal: Lancet Date: 2001-06-09 Impact factor: 79.321

7. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.

Authors: P J Mease; B S Goffe; J Metz; A VanderStoep; B Finck; D J Burge
Journal: Lancet Date: 2000-07-29 Impact factor: 79.321

8. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.

Authors: R S Stern; K T Nichols; L H Väkevä
Journal: N Engl J Med Date: 1997-04-10 Impact factor: 91.245

Immunomodulatory drugs for psoriasis.

Review 1. Novel immunotherapies for psoriasis.

2. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

3. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration.

4. [The role of biologics into the management of psoriasis: a consensus paper by the Psoriasis Study Group, Arbeitsgemeinschaft Dermatologische Forschung].

Review 5. Methotrexate in psoriasis: consensus conference.

6. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial.

7. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.

8. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.

Review 9. Interfering with leukocyte rolling--a promising therapeutic approach in inflammatory skin disorders?

10. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.

1. [Alefacept. Successful long-term therapy of a severe psoriasis].

Review 2. The Inflammatory Response in Psoriasis: a Comprehensive Review.